When either 3H-labeled L-glyceraldehyde or 3H-labeled L-glyceraldehyde 3-phosphate (GAP) was added to cultures of Escherichia coli, the phosphoglycerides were labeled. More than 81% of the label appeared in the backbone of the phosphoglycerides. Chromatographic analyses of the labeled phosphoglycerides revealed that the label was normally distributed into phosphatidylethanolamine, phosphatidylglycerol, and cardiolipin. These results suggest that L-glyceraldehyde is phosphorylated and the resultant L-GAP is converted into sn-glycerol 3-phosphate (G3P) before being incorporated into the bacterial phosphoglycerides. Cell-free bacterial extracts catalyzed an NADPH-dependent reduction of L-GAP to sn-G3P. The partially purified enzyme was specific for L-GAP and recognized neither D-GAP nor (5, 12) . Intracellular L-GAP can also be formed by a glycerokinase-catalyzed phosphorylation of L-glyceraldehyde that is taken up from the growth medium (12). The mechanism by which L-GAP causes E. coli to lose viability is not known.
L-Glyceraldehyde 3-phosphate (GAP) is a bactericidal agent that enters Escherichia coli via either the sn-glycerol 3-phosphate (G3P) or hexose phosphate transport system (5, 12) . Intracellular L-GAP can also be formed by a glycerokinase-catalyzed phosphorylation of L-glyceraldehyde that is taken up from the growth medium (12) . The mechanism by which L-GAP causes E. coli to lose viability is not known.
One possibility is that L-GAP exerts its bactericidal effect by interfering with a critical biochemical reaction. In aqueous solution, L-GAP exists as an equilibrium mixture of the hydrated and free aldehyde in a molar ratio of 29:1 (14) . Since the hydrated form may be considered an analog of sn-G3P, L-GAP has the potential to interfere with enzymes involved in sn-G3P metabolism. L-GAP is a competitive inhibitor of both sn-G3P acyltransferase and phosphatidylglycerol phosphate synthetase (12, 13) . However, these inhibitory activities do not necessarily explain the bactericidal activity of L-GAP. The sn-G3P analogs 3-hydroxy-4-oxobutyl-1-phosphonate and 1,3,4-trihydroxybutyl-1-phosphonate are bacteriostatic rather than bactericidal, even though they also inhibit the two lipid enzymes (13; unpublished 
data).
A second possibility is that L-GAP is not itself bactericidal but is instead a precursor for the true bactericidal agent. L- [3-3H] glyceraldehyde and L- [3-3H] GAP were synthesized to investigate this possibility. While following the metabolic fate of the labeled compounds, it became evident that E. coli has the heretofore unreported ability to convert L-GAP into sn-G3P. This report describes the evidence for the in vivo conversion of L-GAP into sn-G3P as well as for the existence of an NADPH-dependent enzyme that catalyzes the reaction. MATERIALS 10 pAl of 88% formic acid, and the tube was then placed in a boiling-water bath for 2 min. The soluble material was spotted onto Whatmann 3MM chromatography paper and developed in ethyl acetate-formic acid-water (5:2:1). In the solvent extraction method, the assay mixture was identical to that described above. At the indicated times, 10-,ul samples were withdrawn and pipetted into a screw-cap tube containing 30 pul of 2,4-dinitrophenylhydrazine reagent (10 mg of 2,4-dinitrophenylhydrazine and 5 pul of concentrated sulfuric acid dissolved in 2 ml of methanol) and 5 pul of water was added. Capped tubes were incubated for 10 min at 80°C, and then the caps were removed to permit complete solvent evaporation during a continued 20-min incubation. Onetenth milliliter of 10% sodium carbonate (wt/vol) was added to each tube, followed by 10 pul of unlabeled rac-G3P (50 mM) and 0.9 ml of water. The mixture was sequentially extracted with 1.5 ml of chloroform, 0.5 ml of liquified phenol (88%, wt/vol), and twice with 1 ml of chloroform. A portion of the aqueous phase was transferred into a scintillation vial containing 0.5 ml of distilled water and 5 ml of Patterson-Greene scintillation fluid (9) . Experiments with sn-[2-3H]G3P and L-[3-3H]GAP revealed that 62% of the G3P was recovered in the aqueous extract, whereas virtually none of the L-GAP was recovered in this fraction. Furthermore, there was an excellent correlation of results when the solvent extract assay was compared with the chromatographic assay. The solvent extraction method was particularly useful for assaying fractions during enzyme purification. After partial enzyme purification, a spectrophotometric assay was feasible because there were no interfering enzyme activities. In this assay, 1 ml of incubation mixture containing 50 ,umol of triethanolamine hydrochloride, pH 6.8, 150 nmol of NADPH (Sigma type III), the indicated concentration of DL-GAP, and partially purified enzyme. The absorption change at 340 nm was monitored at 30°C in a Gilford model 250 spectrophotometer fitted with a multisample absorbance recorder.
G3P synthetase was assayed as described by Spector and Pizer (11) . Triose phosphate isomerase contamination of various enzyme fractions was detected by monitoring the absorption change at 340 nm of an assay mixture containing 50 pumol of triethanolamine hydrochloride, pH 7.5, 100 nmol of NADH, 0.7 U of rabbit muscle G3P dehydrogenase, 1.6 pLmol of DL-GAP, and enzyme in a final volume of 1 ml. One unit of L-GAP reductase and sn-G3P synthetase activity converts 1 nmol of substrate into product per min at 270C, and 1 U of triose phosphate isomerase activity converts 1 ,umol of substrate into product per min at 27°C.
Bacterial strains and culture conditions. Bicine-buffered minimal medium (B-medium) has been described (12) . The minimal media were supplemented with 0.2 to 0.5% of the indicated carbon source. CH medium contained 1% casein hydrolysate, pH 7.4, and 0.5% sodium chloride. Cell growth and viability were followed as described previously (12) . The bacterial strains used were strain 7 (phoA8 glpRJfhuA22 rel-1 T2r XA (6), strain 8 (strain 7 but glpD) (6), strain 9 (strain 8 but glpK) (6), and strain BB20 (strain 8 but gpsA20) (1). Strain (2) .
Purification of L-GAP reductase. A suspension containing 60 g of bacteria in 600 ml of 20 mM sodium phosphate, pH 7.6, was sonicated in three batches (2 s/ml) with 10-s bursts in a Bronson ultrasonic sonicator at setting 8 (Fig. 1 ).
E. coli glycerokinase is known to catalyze the phosphorylation of L-glyceraldehyde to form L-GAP (7). It therefore seemed possible that L-glyceraldehyde must be converted into L-GAP before it can be incorporated into bacterial phosphoglycerides. This possibility was tested by comparing the incorporation of L-[3-3H]glyceraldehyde and [1-3H]glycerol into the phosphoglycerides of strains 8 and 9 (glpR glpD glpK). As expected, considerably more [1- 3H]glycerol was incorporated into the lipids of strain 8 than into those of strain 9 (Fig. 1) . The same was also true for L-[3-3H]glyceraldehyde (Fig. 1) , suggesting that it must be converted into L-GAP before being incorporated into phosphoglycerides. In support of this hypothesis, the incor- of the label was in the aqueous fraction. These studies indicate that a small but significant proportion of sn-G3P was catabolized by strain 8 even thoulgh it lacks G3P dehydrogenase activity. Together, these results indicate that 81% or more of the label originally associated with L-glyceraldehyde or L-GAP was incorporated into the sn-G3P backbone of the phosphoglycerides. For phosphatidylglycerol and cardiolipin, this of necessity means that the label is present in the glycerol moiety.
The results described thps far can be explained most simply by postulating the following metabolic sequence: (i) glycerokinase-catalyzed phosphorylation of L-glyceraldehyde into L-GAP (or direct uptake of L-GAP), (ii) conversion of L-GAP into sn-G3P, and (iii) incorporation of sn-G3P into phosphoglycerides. Several pathways for the conversion of L-GAP into sn-G3P may be envisioned. The most direct, aldehyde reduction, was the first examhined. Soluble extracts prepared fromn E. coli catalyzed an NADPHdependent reduction of L-GAP to sn-G3P (Fig. 3) . NADH could not replace NADPH. The nature of the product was verified by chromatography in several solvent systems. Furthermore, after alkaline phosphatase hydrolysis, the labeled compound cochromatographed with glycerol. L-GAP reductase activity was found exclusively in the high-speed supernatant of crude extracts (data not shown). Extracts prepared from strain BB20 (gpsA) catalyzed the reduction of L-GAP to sn-G3P (data not shown), indicating that G3P synthetase is not involved in the reduction. ,umol of bicine, pH 7.6, and 18 ,.g of soluble cell extract protein in a final volume of 0.215 ml, was incubated at 27°C for 0 ( ) or 10 min (---). The reaction was stopped as described in the text, and the product was spotted on Whatman 3MM chromatography paper.
The chromatogram was developed in ethyl acetate-formic acidwater (5:2:1).
Before attempting enzyme purification, it was deemed desirable to develop a more convenient assay procedure. The solvent extraction assay described in Materials and Methods is based on the fact that GAP reacts with phenylhydrazine to form a water-insoluble product, whereas G3P does not react and remains water soluble. Identical kinetic results were obtained when the chromatographic and solvent extraction assays were used on the same incubation mixture. The solvent extraction assay was used in most subsequent experiments with crude extracts.
L-GAP reductase activity was extremely low in frozen E. coli paste purchased from a commercial source. This raised the possibility that culture conditions affect enzyme activity. Extracts prepared from cells cultured either in B-medium plus 0.5% potassium succinate or in CH medium had a much higher L-GAP reductase activity than an extract prepared from cells cultured in B-medium plus 0.5% glucose ( Table 1) . The reason for this is unclear. Since some increase in the L-GAP reductase activity was observed when extracts obtained from cells cultured in glucose were dialyzed (data not shown), the effect may be due in part to a low-molecularweight metabolite. However, catabolite repression cannot be ruled out at this stage. The age of the culture also appeared to have some effect on L-GAP reductase activity (Table 1) .
Enzyme was partially purified from strain 8 cultured in CH medium, harvested at 170 Klett units, and stored frozen until needed. The enzyme was partially purified by the process described in Materials and Methods and summarized in Table 2 . The elution profile after chromatography on DEAESephadex A-S0 is shown in Fig. 4 . Because activity could not be recovered from phosphocellulose or hydroxyapatite columns, further attempts at purification were deferred. The partially purified enzyme was free of G3P synthetase activity (EC 1.1.1.94) but had some triose phosphate isomerase activity. Preliminary experiments indicated that the partially purified enzyme was stable after freezing. However, a considerable loss of activity was evident after a year's storage at -18°C. Although no loss in activity was observed after The partially purified enzyme had a pH optimum of approximately 6.6 (Fig. 5 ). Prior to this experiment, assays were performed at pH 7.6. All subsequent assays were run at pH 6.8 in triethanolamine hydrochloride buffer or at pH 6.7 in sodium cacodylate buffer. When L-GAP was present at 79 ,uM, the apparent Km for NADPH was 35 ,uM, and when NADPH was present at 150 ,M, the apparent Km for L-GAP was 28 p,M. Attempts to follow the reaction in the reverse direction have thus far been inconclusive. Neither D-GAP nor dihydroxyacetone phosphate was a substrate for the reductase. The GAP analog rac-3-hydroxy-4-oxobutyl-1-phosphonate was a substrate, with a relatively low apparent Km (0.28 mM). Three other carbonyl compounds, methylglyoxal, L-glyceraldehyde, and D-glyceraldehyde, were poor substrates, with apparent Km of 14, 28, and 100 mM, respectively. Because the enzyme was only partially purified, it is not clear whether recognition of these three carbonyl compounds is due to L-GAP reductase or contaminating activities.
L-GAP reductase was not inhibited by rac-G3P or by the sulfhydryl reagents iodoacetate (0.5 mM), or Nethylmaleimide (2.5 mM), or p-chloromercuribenzoate (0.06 mM). At 0.1 mM, ZnCl2 inhibited L-GAP reductase activity by 28%, while neither CaCl2 nor MgCl2 had any significant effect. At 0.1 and 1.0 mM, MnCl2 stimulated the reductase activity by 28 and 91%, respectively. The manganese ion may interact with NADPH rather than with the enzyme itself (4). At 2 mM, EDTA stimulated activity by 26%. L-GAP:NADPH oxidoreductase activity does not explain the toxicity of L-GAP. On the contrary, it seems to offer a method for detoxifying the compound, since it catalyzes the conversion of L-GAP into the normal metabolite sn-G3P. Therefore, the mechanism by which L-GAP kills E. coli still remains an open question.
Although an enzyme has been discovered that catalyzes the NADPH-dependent reduction of L-GAP into sn-G3P in vitro, its physiological role is not evident. L-GAP is not considered a natural metabolite. It was therefore surprising to discover a reductase that exhibited a rather low Km for L-GAP and a fairly narrow range of substrate specificity. Neither dihydroxyacetone phosphate nor D-GAP, the two natural metabolites that most closely resemble L-GAP, could serve as substrate for the reductase. It is quite probable that the real substrate of the reductase is a natural metabolite that
has not yet been tested. However, if L-GAP is the physiological substrate, then it is necessary to ask why E. coli would have evolved and maintained such an activity.
